Self-amplifying ROS-responsive SN38 prodrug nanoparticles for combined chemotherapy and ferroptosis in cancer treatment
Qin Yu(Shenyang Pharmaceutical University), Ken‐ichiro Kamei(Shenyang Pharmaceutical University), Na Liu(Shenyang Pharmaceutical University), Cong Luo(Chongqing University), Chutong Tian(Shenyang Pharmaceutical University), Fenghui Wang(Shenyang Pharmaceutical University), Zeping Gao(Shenyang Pharmaceutical University)
Cited by 10
Related Papers
Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy
|Journal of Controlled Release|2019|162
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
|Biomedicine & Pharmacotherapy|2024|109
Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system
|Journal of Nanobiotechnology|2022|82
Nimodipine nanocrystals for oral bioavailability improvement: Preparation, characterization and pharmacokinetic studies
|Colloids and Surfaces B Biointerfaces|2013|77
Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel
|Colloids and Surfaces B Biointerfaces|2016|58